International Flavors & Fragrances Inc tiene un precio objetivo de consenso de $86.86 basado en las calificaciones de 23 analistas. El máximo es $112, emitido por Jefferies el enero 12, 2024. El mínimo es $60, emitido por Redburn Atlantic el octubre 12, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por Barclays, UBS y B of A Securities el noviembre 7, 2025, noviembre 6, 2025 y octubre 14, 2025, respectivamente. Con un precio objetivo promedio de $74.33 entre Barclays, UBS y B of A Securities, hay una 19.89% upside implícita para International Flavors & Fragrances Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/07/2025 | 20.97% | Barclays | $72 → $75 | Maintains | Overweight | |||
11/06/2025 | 9.68% | UBS | $66 → $68 | Maintains | Neutral | |||
10/14/2025 | 29.03% | B of A Securities | $84 → $80 | Maintains | Buy | |||
10/07/2025 | 12.9% | Argus Research | $85 → $70 | Maintains | Buy | |||
10/06/2025 | 6.45% | UBS | $71 → $66 | Maintains | Neutral | |||
10/06/2025 | 20.97% | Citigroup | $82 → $75 | Maintains | Buy | |||
10/03/2025 | 20.97% | Mizuho | $85 → $75 | Maintains | Outperform | |||
09/22/2025 | 45.16% | Morgan Stanley | $92 → $90 | Maintains | Overweight | |||
09/08/2025 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
08/26/2025 | 69.35% | Tigress Financial | $105 → $105 | Maintains | Buy | |||
08/08/2025 | 25.81% | Barclays | $84 → $78 | Maintains | Overweight | |||
08/07/2025 | 37.1% | Wells Fargo | $90 → $85 | Maintains | Overweight | |||
08/06/2025 | 27.42% | UBS | $83 → $79 | Maintains | Neutral | |||
06/04/2025 | 69.35% | Tigress Financial | → $105 | Initiates | → Buy | |||
05/13/2025 | 58.06% | Morgan Stanley | $100 → $98 | Maintains | Overweight | |||
05/08/2025 | 45.16% | Citigroup | $84 → $90 | Maintains | Buy | |||
05/08/2025 | 61.29% | Baird | $110 → $100 | Maintains | Outperform | |||
05/08/2025 | 35.48% | Barclays | $76 → $84 | Upgrade | Equal-Weight → Overweight | |||
05/07/2025 | 33.87% | UBS | $82 → $83 | Maintains | Neutral | |||
04/22/2025 | 43.55% | Oppenheimer | $104 → $89 | Maintains | Outperform | |||
04/15/2025 | 40.32% | Mizuho | $95 → $87 | Maintains | Outperform | |||
04/14/2025 | 22.58% | Barclays | $82 → $76 | Maintains | Equal-Weight | |||
04/10/2025 | 61.29% | Morgan Stanley | $106 → $100 | Maintains | Overweight | |||
04/10/2025 | 46.77% | Stifel | $105 → $91 | Maintains | Buy | |||
04/09/2025 | 45.16% | Wells Fargo | $105 → $90 | Maintains | Overweight | |||
04/08/2025 | 35.48% | Citigroup | $99 → $84 | Maintains | Buy | |||
03/27/2025 | 32.26% | Barclays | $83 → $82 | Maintains | Equal-Weight | |||
02/20/2025 | 67.74% | Oppenheimer | $114 → $104 | Maintains | Outperform | |||
02/20/2025 | 67.74% | JP Morgan | $107 → $104 | Maintains | Overweight | |||
02/20/2025 | 62.9% | B of A Securities | $105 → $101 | Maintains | Buy | |||
02/20/2025 | 69.35% | Wells Fargo | $115 → $105 | Maintains | Overweight | |||
02/03/2025 | 69.35% | Stifel | $113 → $105 | Maintains | Buy | |||
01/28/2025 | 83.87% | Oppenheimer | $117 → $114 | Maintains | Outperform | |||
01/17/2025 | 41.94% | Barclays | $90 → $88 | Maintains | Equal-Weight | |||
01/07/2025 | — | Argus Research | — | Upgrade | Hold → Buy | |||
12/18/2024 | 69.35% | Citigroup | $110 → $105 | Maintains | Buy | |||
11/12/2024 | 77.42% | Morgan Stanley | $111 → $110 | Upgrade | Equal-Weight → Overweight | |||
11/08/2024 | 72.58% | B of A Securities | $109 → $107 | Upgrade | Neutral → Buy | |||
11/07/2024 | 72.58% | JP Morgan | $110 → $107 | Maintains | Overweight | |||
11/07/2024 | 75.81% | Vertical Research | — | → $109 | Upgrade | Hold → Buy | ||
11/06/2024 | 79.03% | UBS | $108 → $111 | Maintains | Neutral | |||
10/24/2024 | 95.16% | Stifel | $115 → $121 | Maintains | Buy | |||
10/11/2024 | 59.68% | Barclays | $93 → $99 | Maintains | Equal-Weight | |||
09/11/2024 | 88.71% | Oppenheimer | $116 → $117 | Maintains | Outperform | |||
09/06/2024 | 77.42% | JP Morgan | $102 → $110 | Maintains | Overweight | |||
09/03/2024 | 93.55% | Mizuho | $109 → $120 | Upgrade | Neutral → Outperform | |||
08/15/2024 | 66.13% | UBS | $107 → $103 | Maintains | Neutral | |||
08/08/2024 | 64.52% | JP Morgan | $100 → $102 | Maintains | Overweight | |||
08/08/2024 | 85.48% | Wells Fargo | $110 → $115 | Maintains | Overweight | |||
08/07/2024 | 72.58% | UBS | $100 → $107 | Maintains | Neutral | |||
07/22/2024 | 85.48% | Stifel | $95 → $115 | Upgrade | Hold → Buy | |||
07/12/2024 | 87.1% | Citigroup | $108 → $116 | Maintains | Buy | |||
07/09/2024 | 61.29% | UBS | $95 → $100 | Maintains | Neutral | |||
07/03/2024 | 66.13% | Morgan Stanley | $100 → $103 | Maintains | Equal-Weight | |||
06/07/2024 | 87.1% | Oppenheimer | → $116 | Initiates | → Outperform | |||
05/21/2024 | 61.29% | Morgan Stanley | $100 → $100 | Downgrade | Overweight → Equal-Weight | |||
05/10/2024 | 59.68% | B of A Securities | $87 → $99 | Maintains | Neutral | |||
05/08/2024 | 74.19% | Citigroup | $100 → $108 | Maintains | Buy | |||
05/08/2024 | 50% | Barclays | $82 → $93 | Maintains | Equal-Weight | |||
05/08/2024 | 77.42% | Wells Fargo | $100 → $110 | Maintains | Overweight | |||
05/08/2024 | 61.29% | JP Morgan | $75 → $100 | Upgrade | Neutral → Overweight | |||
05/08/2024 | 77.42% | Baird | $100 → $110 | Maintains | Outperform | |||
05/07/2024 | 53.23% | Stifel | $87 → $95 | Maintains | Hold | |||
05/07/2024 | 58.06% | Mizuho | $91 → $98 | Maintains | Neutral | |||
04/12/2024 | 20.97% | Barclays | $69 → $75 | Maintains | Underweight | |||
04/10/2024 | 61.29% | Citigroup | $81 → $100 | Upgrade | Neutral → Buy | |||
04/04/2024 | 61.29% | Wells Fargo | $90 → $100 | Maintains | Overweight | |||
03/27/2024 | 54.84% | Morgan Stanley | $89 → $96 | Maintains | Overweight | |||
03/20/2024 | 61.29% | Deutsche Bank | $90 → $100 | Maintains | Buy | |||
03/20/2024 | 46.77% | Mizuho | $83 → $91 | Maintains | Neutral | |||
03/08/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Underperform | |||
02/26/2024 | 33.87% | Mizuho | $82 → $83 | Maintains | Neutral | |||
02/23/2024 | 30.65% | Citigroup | $85 → $81 | Maintains | Neutral | |||
02/22/2024 | 45.16% | Wells Fargo | $85 → $90 | Maintains | Overweight | |||
02/22/2024 | 37.1% | Baird | $80 → $85 | Maintains | Outperform | |||
02/21/2024 | 32.26% | Mizuho | $86 → $82 | Maintains | Neutral | |||
02/21/2024 | 29.03% | Stifel | $87 → $80 | Maintains | Hold | |||
01/22/2024 | 45.16% | Morgan Stanley | $81 → $90 | Upgrade | Equal-Weight → Overweight | |||
01/12/2024 | 11.29% | Barclays | $64 → $69 | Maintains | Underweight | |||
01/12/2024 | 80.65% | Jefferies | $73 → $112 | Upgrade | Hold → Buy | |||
01/11/2024 | 32.26% | UBS | $78 → $82 | Maintains | Neutral | |||
12/20/2023 | 40.32% | Stifel | $81 → $87 | Maintains | Hold | |||
12/06/2023 | 30.65% | Morgan Stanley | $75 → $81 | Maintains | Equal-Weight | |||
11/28/2023 | 37.1% | Argus Research | → $85 | Upgrade | Hold → Buy | |||
11/13/2023 | 25.81% | UBS | $88 → $78 | Downgrade | Buy → Neutral | |||
11/08/2023 | 37.1% | Wells Fargo | $80 → $85 | Maintains | Overweight | |||
11/07/2023 | 40.32% | Stifel | $77 → $87 | Maintains | Hold | |||
10/12/2023 | -8.06% | Barclays | $60 → $57 | Maintains | Underweight | |||
10/12/2023 | -3.23% | Redburn Atlantic | → $60 | Initiates | → Neutral | |||
09/14/2023 | 30.65% | Stifel | $81 → $81 | Reiterates | Hold → Hold | |||
08/24/2023 | 20.97% | Morgan Stanley | $112 → $75 | Downgrade | Overweight → Equal-Weight | |||
08/10/2023 | 25.81% | Goldman Sachs | $120 → $78 | Maintains | Neutral | |||
08/10/2023 | -3.23% | Barclays | $75 → $60 | Maintains | Underweight | |||
08/09/2023 | 8.06% | JP Morgan | $83 → $67 | Maintains | Neutral | |||
08/09/2023 | 37.1% | Deutsche Bank | $110 → $85 | Maintains | Buy | |||
08/09/2023 | 29.03% | Wells Fargo | $93 → $80 | Maintains | Overweight | |||
08/09/2023 | 25.81% | Goldman Sachs | $120 → $78 | Downgrade | Buy → Neutral | |||
08/09/2023 | 12.9% | Citigroup | $84 → $70 | Maintains | Neutral | |||
08/08/2023 | 53.23% | Credit Suisse | $110 → $95 | Maintains | Outperform |
El último precio objetivo de Intl Flavors & Fragrances (NYSE:IFF) fue comunicado por Barclays el noviembre 7, 2025. La firma de analistas fijó un precio objetivo para $75.00 que espera IFF a rise dentro de 12 meses (un posible 20.97% upside). 37 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Intl Flavors & Fragrances (NYSE:IFF) fue proporcionada por Barclays, y Intl Flavors & Fragrances mantuvo su overweight calificación.
La última revisión al alza de International Flavors & Fragrances Inc se produjo en septiembre 8, 2025, cuando Wolfe Research elevó su precio objetivo a N/A. Wolfe Research anteriormente tenía an underperform para International Flavors & Fragrances Inc.
La última revisión a la baja de International Flavors & Fragrances Inc se produjo en mayo 21, 2024, cuando Morgan Stanley cambió su precio objetivo de $100 a $100 para International Flavors & Fragrances Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Intl Flavors & Fragrances, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Intl Flavors & Fragrances se registró el noviembre 7, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 7, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Intl Flavors & Fragrances (IFF) fue un mantuvo con un precio objetivo de $72.00 a $75.00. El precio actual al que cotiza Intl Flavors & Fragrances (IFF) es de $62.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.